# A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

> **NCT06144086** · PHASE2 · COMPLETED · sponsor: **Kiminori Kimura, MD** · enrollment: 5 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Foscenvivint

## Key facts

- **NCT ID:** NCT06144086
- **Lead sponsor:** Kiminori Kimura, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-08
- **Primary completion:** 2025-03-27
- **Final completion:** 2025-03-27
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06144086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06144086, "A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06144086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*